• Brief
  • Portfolio
  • Ask
  • Network

SUNPHARMA

Sun Pharmaceutical Industries Ltd · Pharma

₹1,872+0.1% today

OverviewResearchPeopleNews

In the news

secondary · not used in research
  • Organon earnings on deck as Sun Pharma merger awaits approvalInvesting.com · 10d ago
  • Organon stock: Sun Pharma deal remains a growth driverad-hoc-news.de · 13d ago
  • Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This YearSimply Wall St · 16d ago
  • 7 more headlinesShow fewer
    • Sun Pharma's profit falls on Organon deal charge; specialty drug sales remain strongReuters · 19d ago
    • Sun Pharmaceutical Q2 FY27 result: Net profit declines 36% YoY; US formulation sales falls to $455 millionUpstox · 19d ago
    • Sun Pharma Q2 results: Net profit falls 36% to Rs 1,989 cr on one-time hit, revenue up 12%; stock jumpsMoneycontrol.com · 19d ago
    • Sun Pharma eyes $4 billion loan for Organon buy, five banks likely to anchor refinancingThe Economic Times · 3d ago
    • Sun Pharma gets NSE, BSE nod to reclassify Valia family as public shareholdersscanx.trade · 3d ago
    • SUNPHARMA Outlook for the WeekEquitypandit · 5d ago
    • Muhurat Trading 2026: Sensex, Nifty open higher in special session; Tata Steel, Sun Pharma shares among top gainersBusiness Today · 10d ago